Armata Pharmaceuticals, Inc. (ARMP) shareholders
Close on Nov 17, 2026Market cap $98.90MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Innoviva, Inc. Joint filing with Innoviva Strategic Opportunities LLC (69.70%) | 55,467,459 | 82.70% | 13D (active) amendment | May 12, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of ARMP | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Madison Asset Management, LLC | 2,107,175 | 5.67% | $13.65M | −500 | 0.16% |
| BlackRock, Inc. | 559,986 | 1.51% | $3.63M | +494,936 | 0.00% |
| Vanguard Capital Management LLC | 487,968 | 1.31% | $3.16M | +121,940 | 0.00% |
| Millennium Management LLC | 470,500 | 1.27% | $3.05M | +212,508 | 0.00% |
| Geode Capital Management, LLC | 270,550 | 0.73% | $1.75M | +155,995 | 0.00% |
| Dauntless Investment Group, LLC | 203,891 | 0.55% | $1.32M | +113,311 | 1.04% |
| State Street Corp | 129,600 | 0.35% | $839.81K | +78,800 | 0.00% |
| Northern Trust Corp | 89,791 | 0.24% | $581.85K | +65,145 | 0.00% |
| Vanguard Portfolio Management LLC | 81,354 | 0.22% | $527.17K | New | 0.00% |
| Edgewood Management LLC | 80,000 | 0.22% | $518.40K | −20,000 | 0.01% |
| Vanguard Fiduciary Trust Co | 79,495 | 0.21% | $515.13K | +11,631 | 0.00% |
| GSB Wealth Management, LLC | 50,000 | 0.13% | $324.00K | +20,000 | 0.07% |
| Renaissance Technologies LLC | 48,318 | 0.13% | $313.10K | +9,822 | 0.00% |
| Bridgeway Capital Management, LLC | 44,682 | 0.12% | $289.54K | – | 0.01% |
| SeaCrest Wealth Management, LLC | 41,524 | 0.11% | $269.08K | – | 0.03% |
| Bank of New York Mellon Corp | 29,749 | 0.08% | $192.77K | New | 0.00% |
| Charles Schwab Investment Management Inc | 28,857 | 0.08% | $186.99K | New | 0.00% |
| Hudson Bay Capital Management LP | 17,584 | 0.05% | $113.94K | – | 0.00% |
| Nuveen, LLC | 15,905 | 0.04% | $103.06K | New | 0.00% |
| New York State Common Retirement Fund | 15,400 | 0.04% | $99.79K | New | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 53 | 5M | 13.4% | 19 / 17 | 3 / 11 | 2M | 0M |
| Q1 2026 | 45 | 4M | 10.6% | 13 / 11 | 4 / 3 | 3M | 0M |
| Q4 2025 | 36 | 1M | 3.4% | 12 / 11 | 1 / 4 | 0M | 0M |
| Q3 2025 | 28 | 1M | 2.0% | 2 / 5 | 3 / 3 | 0M | 0M |
| Q2 2025 | 29 | 1M | 2.0% | 5 / 5 | 4 / 2 | 0M | 0M |
| Q1 2025 | 26 | 1M | 2.0% | 2 / 2 | 9 / 0 | 0M | 1M |
| Q4 2024 | 24 | 1M | 3.7% | 2 / 4 | 7 / 2 | 0M | 0M |
| Q3 2024 | 24 | 1M | 3.7% | 4 / 5 | 6 / 2 | 0M | 0M |
| Q2 2024 | 23 | 1M | 3.8% | 0 / 6 | 11 / 1 | 0M | 0M |
| Q1 2024 | 24 | 1M | 3.8% | 2 / 7 | 8 / 3 | 0M | 0M |
| Q4 2023 | 25 | 1M | 3.5% | 3 / 6 | 5 / 1 | 0M | 0M |
| Q3 2023 | 23 | 1M | 3.4% | 4 / 5 | 3 / 3 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
38 funds held ARMP in Q2 2026, 78% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of ARMP | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 349,598 | 0.94% | $2.27M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 197,072 | 0.53% | $1.28M | 0.00% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 128,856 | 0.35% | $585.01K | 0.00% | Jul 31, 2026 |
| Vanguard Extended Market Index Fund | 125,873 | 0.34% | $815.66K | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 Growth ETF | 111,368 | 0.30% | $721.66K | 0.00% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 56,701 | 0.15% | $463.25K | 0.00% | May 31, 2026 |
| Ultra-Small Company Market Fund | 41,382 | 0.11% | $268.16K | 0.18% | Jun 30, 2026 |
| iShares Micro-Cap ETF | 39,743 | 0.11% | $257.53K | 0.02% | Jun 30, 2026 |
| Schwab Small-Cap Index Fund | 28,857 | 0.08% | $131.01K | 0.00% | Jul 31, 2026 |
| Master Small Cap Index Series | 22,168 | 0.06% | $143.65K | 0.00% | Jun 30, 2026 |
| Fidelity Total Market Index Fund | 17,296 | 0.05% | $141.31K | 0.00% | May 31, 2026 |
| Fidelity Series Total Market Index Fund | 16,271 | 0.04% | $132.93K | 0.00% | May 31, 2026 |
| Nuveen Small Cap Blend Index Fund | 15,905 | 0.04% | $72.21K | 0.00% | Jul 31, 2026 |
| Fidelity Small Cap Growth Index Fund | 11,252 | 0.03% | $72.91K | 0.00% | Jun 30, 2026 |
| EQ/2000 Managed Volatility Portfolio | 11,164 | 0.03% | $72.34K | 0.00% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Deborah Birx | Chief Executive Officer, Director | 198,417 | 0.53% | Jul 14, 2026 |
| Pierre Kyme | Chief Business Officer | 9,461 | 0.03% | Mar 17, 2026 |
| David Duane House | SVP, Finance, and PFO | – | – | Mar 11, 2026 |
| Daniel B. Gilmer | Director | – | – | Apr 28, 2026 |
| Jules Haimovitz | Director | – | – | Mar 11, 2026 |
| Sarah J. Schlesinger | Director | – | – | Mar 11, 2026 |
| Todd C. Peterson | Director | – | – | Mar 11, 2026 |
| Robin Kramer | Director | – | – | Mar 11, 2026 |
| Joseph M. Patti | Director | – | – | Mar 11, 2026 |
| Kostas D. Odysseas | Director | – | – | Mar 11, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Deborah Birx Chief Executive Officer, Director | Jul 10, 2026 | Tax withholding | −14,041 | $4.26 | $59.81K | 198,417 |
| Deborah Birx Chief Executive Officer, Director | Mar 14, 2026 | Tax withholding | −4,919 | $10.54 | $51.85K | 212,458 |
| Pierre Kyme Chief Business Officer | Mar 14, 2026 | Tax withholding | −1,030 | $10.54 | $10.86K | 9,461 |
| Deborah Birx Chief Executive Officer, Director | Jul 10, 2025 | Tax withholding | −13,637 | $2.27 | $30.96K | 217,377 |
| Deborah Birx Chief Executive Officer, Director | Mar 14, 2025 | Tax withholding | −6,061 | $1.95 | $11.82K | 231,014 |
| Pierre Kyme Chief Business Officer | Mar 14, 2025 | Tax withholding | −1,027 | $1.95 | $2.00K | 10,491 |
| Deborah Birx Chief Executive Officer, Director | Jul 10, 2024 | Tax withholding | −22,925 | $2.68 | $61.44K | 237,075 |
| Richard Rychlik Corporate Controller and PFO | Mar 14, 2024 | Award | +10,000 | – | – | 10,000 |
| Deborah Birx Chief Executive Officer, Director | Mar 14, 2024 | Award | +60,000 | – | – | 260,000 |
| Deborah Birx Chief Executive Officer, Director | Dec 21, 2023 | Award | +200,000 | – | – | 200,000 |
| Innoviva, Inc. Director, 10% owner | Mar 31, 2022 | Buy | +5,385,208 | $5.00 | $26.93M | 16,365,969 |
| Strategic Opportunities LLC Innoviva Director, 10% owner | Feb 9, 2022 | Buy | +3,614,792 | $5.00 | $18.07M | 10,980,761 |
| Strategic Opportunities LLC Innoviva Director, 10% owner | Oct 29, 2021 | Buy | +1,212,122 | $3.30 | $4.00M | 7,365,969 |
| Innoviva, Inc. Director, 10% owner | Mar 17, 2021 | Buy | +4,285,935 | $3.25 | $13.93M | 6,153,847 |
| Strategic Opportunities LLC Innoviva Director, 10% owner | Jan 26, 2021 | Buy | +1,867,912 | $3.25 | $6.07M | 1,867,912 |
| Innoviva, Inc. 10% owner | Mar 27, 2020 | Buy | +7,717,661 | $2.87 | $22.15M | 8,710,800 |
| Michael S. Perry Director | Mar 22, 2018 | Buy | +181,820 | $1.10 | $200.00K | 411,105 |
| Jeremy Curnock Cook Director | Mar 22, 2018 | Buy | +181,820 | $1.10 | $200.00K | 411,105 |
| Paul C. Grint Chief Executive Officer, Director | Dec 8, 2017 | Award | +599 | $0.62 | $371 | 599 |
| Michael S. Perry Director | Sep 19, 2017 | Buy | +105,015 | – | – | 229,285 |
| Jeremy Curnock Cook Director | Sep 19, 2017 | Buy | +105,015 | – | – | 229,285 |
| Michael S. Perry Director | Jun 29, 2017 | Buy | +5,757 | – | – | 124,270 |
| Jeremy Curnock Cook Director | Jun 29, 2017 | Buy | +5,757 | – | – | 124,270 |
| Randal J. Kirk 10% owner | Dec 29, 2016 | Sale | −20,077 | $0.45 | $9.03K | 674,169 |
| Randal J. Kirk 10% owner | Dec 29, 2016 | Sale | −21,923 | $0.45 | $9.87K | 736,170 |
| Randal J. Kirk 10% owner | Dec 28, 2016 | Sale | −44,170 | $0.47 | $20.76K | 758,093 |
| Randal J. Kirk 10% owner | Dec 28, 2016 | Sale | −40,450 | $0.47 | $19.01K | 694,246 |
| Randal J. Kirk 10% owner | Dec 27, 2016 | Sale | −26,308 | $0.51 | $13.42K | 802,263 |
| Randal J. Kirk 10% owner | Dec 27, 2016 | Sale | −24,092 | $0.51 | $12.29K | 734,696 |
| Michael Scott Salka Chief Executive Officer, Director | Dec 9, 2016 | Award | +7,000 | $0.39 | $2.73K | 11,200 |
| Steven Robert Martin Chief Financial Officer | Dec 9, 2016 | Award | +3,760 | $0.39 | $1.47K | 3,760 |
| Jeremy Curnock Cook Director | Nov 22, 2016 | Buy | +46,666 | $7.40 | $345.33K | 118,513 |
| Randal J. Kirk 10% owner | Nov 12, 2016 | Conversion | +428,571 | – | – | 828,571 |
| Jeremy Curnock Cook Director | Jun 21, 2016 | Buy | +15,057 | – | – | 71,847 |
| Jeremy Curnock Cook Director | Apr 8, 2016 | Buy | +171,298 | – | – | 567,903 |
| Jeremy Curnock Cook Director | Apr 8, 2016 | Conversion | +208,150 | – | – | 396,605 |
| Louis Drapeau Director | Oct 6, 2015 | Buy | +10,000 | $4.39 | $43.90K | 10,000 |
| Wendy S. Johnson Interim Chief Operating Office, Director | Oct 5, 2015 | Buy | +1,000 | $4.43 | $4.43K | 1,000 |
| Michael Scott Salka Chief Executive Officer, Director | Oct 5, 2015 | Buy | +4,200 | $4.75 | $19.95K | 4,200 |
| Jeremy Curnock Cook Director | Mar 16, 2015 | Buy | +68,455 | $8.25 | $564.75K | 188,455 |
| Corp Intrexon 10% owner | Mar 16, 2015 | Buy | +13,939,392 | $0.17 | $2.37M | 37,939,392 |
| Jeremy Curnock Cook Director | May 27, 2010 | Award | +70,000 | – | – | 100,000 |
| Michael S. Perry Director | May 27, 2010 | Award | +50,000 | – | – | 70,000 |
| David J. Poston Vice President and CFO | Apr 16, 2010 | Tax withholding | −66,125 | $0.22 | $14.55K | 220,576 |
| David J. Poston Vice President and CFO | Apr 16, 2010 | Award | +500,000 | – | – | 36,701 |
| BG Susan Robinson President and CEO, Director | Apr 16, 2010 | Tax withholding | −99,187 | $0.22 | $21.82K | 310,814 |
| BG Susan Robinson President and CEO, Director | Apr 16, 2010 | Award | +750,000 | – | – | 35,001 |
| Austin W. & Greenhouse David M. Marxe 10% owner | Oct 12, 2009 | Sale | −675,000 | $0.26 | $175.50K | 0 |
| Austin W. & Greenhouse David M. Marxe 10% owner | Oct 9, 2009 | Sale | −200,000 | $0.26 | $52.00K | 675,000 |
| Austin W. & Greenhouse David M. Marxe 10% owner | Oct 8, 2009 | Sale | −1,120,481 | $0.26 | $291.33K | 875,000 |
| Austin W. & Greenhouse David M. Marxe 10% owner | Oct 7, 2009 | Sale | −200,000 | $0.30 | $60.00K | 1,995,481 |
| Austin W. & Greenhouse David M. Marxe 10% owner | Sep 9, 2009 | Sale | −60,000 | $0.53 | $31.80K | 2,195,481 |
| Austin W. & Greenhouse David M. Marxe 10% owner | Sep 9, 2009 | Sale | −100,000 | $0.50 | $50.00K | 2,255,481 |
| Austin W. & Greenhouse David M. Marxe 10% owner | Jun 5, 2009 | Sale | −900 | $0.50 | $450 | 2,355,475 |
| Austin W. & Greenhouse David M. Marxe 10% owner | Jun 3, 2009 | Sale | −145,552 | $0.05 | $7.28K | 2,356,375 |
| David J. Poston Vice President and CFO | May 17, 2009 | Tax withholding | −3,085 | $0.21 | $648 | 65,530 |
| BG Susan Robinson President and CEO, Director | May 17, 2009 | Tax withholding | −3,809 | $0.21 | $800 | 59,297 |
| David J. Poston Vice President and CFO | May 15, 2009 | Tax withholding | −3,085 | $0.21 | $648 | 68,615 |
| BG Susan Robinson President and CEO, Director | May 15, 2009 | Tax withholding | −3,809 | $0.21 | $800 | 63,106 |
| Austin W. & Greenhouse David M. Marxe 10% owner | Jun 23, 2008 | Sale | −399 | $0.67 | $267 | 2,501,927 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Armata Pharmaceuticals's stock actually held short. Settlement fails (shares not delivered on time) peaked at 5,098 shares on Sep 16, 2026 over the last 90 days.
See a number that looks wrong?